Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.5.0.2
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Revenue:        
Contract research revenue $ 0 $ 77,000 $ 0 $ 134,636
Costs and Expenses:        
Research and development 642,576 1,354,728 1,564,287 2,803,141
General and administrative 977,653 1,124,066 2,293,430 2,301,907
Total costs and expenses 1,620,229 2,478,794 3,857,717 5,105,048
Loss from operations (1,620,229) (2,401,794) (3,857,717) (4,970,412)
Other expense, net (3,656) (2,738) (10,778) (4,231)
Net loss $ (1,623,885) $ (2,404,532) $ (3,868,495) $ (4,974,643)
Net loss per share - basic and diluted (in dollars per share) $ (0.03) $ (0.04) $ (0.07) $ (0.11)
Weighted average common shares outstanding:        
Basic and diluted (in shares) 57,593,414 55,942,013 57,440,645 45,815,657